Liver transplantation for primary biliary cirrhosis

Research output: Contribution to journalReview article


  • James Neuberger

Colleges, School and Institutes


Liver transplantation is now the accepted treatment for patients with end-stage disease or intractable symptoms. The success rate is high. Those grafted for PBC are at greater risk of developing acute and chronic rejection and are less likely to be weaned from immunosuppression. Following transplantation, AMA persist and histological features of PBC may be seen in the allograft, in up to 50% by 10 years.


Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalAutoimmunity Reviews
Issue number1
Publication statusPublished - 1 Jan 2003